1. Home
  2. MDAIW vs DBD Comparison

MDAIW vs DBD Comparison

Compare MDAIW & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • DBD
  • Stock Information
  • Founded
  • MDAIW N/A
  • DBD 1859
  • Country
  • MDAIW United States
  • DBD United States
  • Employees
  • MDAIW 78
  • DBD N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • DBD EDP Services
  • Sector
  • MDAIW Health Care
  • DBD Technology
  • Exchange
  • MDAIW Nasdaq
  • DBD Nasdaq
  • Market Cap
  • MDAIW N/A
  • DBD N/A
  • IPO Year
  • MDAIW N/A
  • DBD N/A
  • Fundamental
  • Price
  • MDAIW $0.31
  • DBD $46.25
  • Analyst Decision
  • MDAIW
  • DBD Strong Buy
  • Analyst Count
  • MDAIW 0
  • DBD 2
  • Target Price
  • MDAIW N/A
  • DBD $65.00
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • DBD 151.6K
  • Earning Date
  • MDAIW 02-27-2025
  • DBD 05-07-2025
  • Dividend Yield
  • MDAIW N/A
  • DBD N/A
  • EPS Growth
  • MDAIW N/A
  • DBD N/A
  • EPS
  • MDAIW N/A
  • DBD N/A
  • Revenue
  • MDAIW $27,264,000.00
  • DBD $3,696,800,000.00
  • Revenue This Year
  • MDAIW N/A
  • DBD $1.70
  • Revenue Next Year
  • MDAIW N/A
  • DBD $1.89
  • P/E Ratio
  • MDAIW N/A
  • DBD N/A
  • Revenue Growth
  • MDAIW 44.52
  • DBD N/A
  • 52 Week Low
  • MDAIW $0.08
  • DBD $34.38
  • 52 Week High
  • MDAIW $0.90
  • DBD $51.81
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • DBD 60.54
  • Support Level
  • MDAIW N/A
  • DBD $43.61
  • Resistance Level
  • MDAIW N/A
  • DBD $46.64
  • Average True Range (ATR)
  • MDAIW 0.00
  • DBD 1.36
  • MACD
  • MDAIW 0.00
  • DBD 0.30
  • Stochastic Oscillator
  • MDAIW 0.00
  • DBD 91.31

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: